2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

10. Carstensen M, Sorensen JB. Outpatient management of febrile neutropenia:
time to revise the present treatment strategy. J Support Oncol.
2008;6:199-208.
11. Talcott JA, Yeap BY, Clark JA, et al. Safety of early discharge for
low-risk patients with febrile neutropenia: a multicenter randomized controlled
trial. J Clin Oncol. 2011;29:3977-3983.
12. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational
Association for Supportive Care in Cancer risk index: A multinational scoring
system for identifying low-risk febrile neutropenic cancer patients. J Clin
Oncol. 2000;18:3038-3051.
13. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline
for the use of antimicrobial agents in neutropenic patients with cancer: 2010
update by the Infectious Diseases Society of America. Clin Infect Dis.
2011;52:e56-93.
14. Ammann RA, Simon A, de Bont ES. Low risk episodes of fever and
neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the
new gold standard of care? Pediatr Blood Cancer. 2005;45:244-247.
15. Teuffel O, Ethier MC, Alibhai SM, et al. Outpatient management of
cancer patients with febrile neutropenia: a systematic review and metaanalysis.
Ann Oncol. 2011;22:2358-2365.
16. Ahmed N, El-Mahallawy HA, Ahmed IA, et al. Early hospital discharge
versus continued hospitalization in febrile pediatric cancer patients with
prolonged neutropenia: A randomized, prospective study. Pediatr Blood
Cancer. 2007;49:786-792.
17. Santolaya ME, Alvarez AM, Aviles CL, et al. Early hospital discharge
followed by outpatient management versus continued hospitalization of
children with cancer, fever, and neutropenia at low risk for invasive bacterial
infection. J Clin Oncol. 2004;22:3784-3789.
18. Manji A, Beyene J, Dupuis LL, et al. Outpatient and oral antibiotic
management of low-risk febrile neutropenia are effective and safe in children—a
systematic review of prospective trials. Poster presented at: 2011
Annual Pediatric Oncology Group of Ontario Symposium; November 2011;
Toronto, ON, Canada.
19. Liou SY, Stephens JM, Carpiuc KT, et al. Economic burden of haematological
adverse effects in cancer patients: a systematic review. Clin Drug
Investig. 2007;27:381-396.
20. Lathia N, Mittmann N, DeAngelis C, et al. Evaluation of direct medical
costs of hospitalization for febrile neutropenia. Cancer. 2010;116:742-748.
574
LILLIAN SUNG
21. Hendricks AM, Loggers ET, Talcott JA. Costs of home versus inpatient
treatment for fever and neutropenia: analysis of a multicenter randomized
trial. J Clin Oncol. 2011;29:3984-3989.
22. Klaassen RJ, Allen U, Doyle JJ. Randomized placebo-controlled trial of
oral antibiotics in pediatric oncology patients at low-risk with fever and
neutropenia. J Pediatr Hematol Oncol. 2000;22:405-411.
23. Wiernikowski JT, Rothney M, Dawson S, et al. Evaluation of a home
intravenous antibiotic program in pediatric oncology. Am J Pediatr Hematol
Oncol. 1991;13:144-147.
24. Teuffel O, Amir E, Alibhai SM, et al. Cost-effectiveness of outpatient
management for febrile neutropenia in children with cancer. Pediatrics.
2011;127:e279-286.
25. Speyer E, Herbinet A, Vuillemin A, et al. Agreement between children
with cancer and their parents in reporting the child’s health-related quality of
life during a stay at the hospital and at home. Child Care Health Dev.
2009;35:489-495.
26. Sung L, Feldman BM, Schwamborn G, et al. Inpatient versus outpatient
management of low-risk pediatric febrile neutropenia: measuring parents’
and healthcare professionals’ preferences. J Clin Oncol. 2004;22:3922-
3929.
27. Cheng S, Teuffel O, Ethier MC, et al. Health-related quality of life
anticipated with different management strategies for paediatric febrile neutropaenia.
Br J Cancer. 2011;105:606-611.
28. Sung L, Alibhai SM, Ethier MC, et al. Discrete choice experiment
produced estimates of acceptable risk of therapeutic options in cancer patients
with febrile neutropenia. J Clin Epidemiol. 2012. In press.
29. Ryan M, Farrar S. Using conjoint analysis to elicit preferences for
health care. BMJ. 2000;320:1530-1533.
30. Diorio C, Martino J, Boydell KM, et al. Parental perspectives on
inpatient versus outpatient management of pediatric febrile neutropenia.
J Pediatr Oncol Nurs. 2011;28:355-362.
31. Ungar WJ. Economic Evaluation in Child Health. Oxford: Oxford
University Press; 2010.
32. Upton P, Lawford J, Eiser C. Parent-child agreement across child
health-related quality of life instruments: a review of the literature. Qual Life
Res. 2008;17:895-913.